March 8, 2021
BURLINGTON, Ontario March 8, 2021 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film infused with an active...
January 11, 2021
BURLINGTON, Ontario January 11, 2021 – Rapid Dose Therapeutics Corp. “RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce that it has entered into a binding Letter of Intent “LOI”)...
December 21, 2020
BURLINGTON, Ontario December 21, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, has worked diligently with its customer, Thrive Cannabis Inc. (“Thrive”), this past year preparing to...
December 15, 2020
BURLINGTON, Ontario – December 15, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce the closing of the first tranche of a Non-Brokered Private...
November 25, 2020
BURLINGTON, Ontario – November 25, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it signed a definitive agreement with ESJ Enterprises, LLC. RDT...
November 19, 2020
BURLINGTON, Ontario – November 19, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has, as of November 18, 2020, received a Revocation...
September 29, 2020
BURLINGTON, Ontario – September 29, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has amended the agreement with Aphria Inc. (TSE:APHA, Nasdaq:APHA)...
August 13, 2020
Burlington, Ontario – August 13, 2020 – Rapid Dose Therapeutics Corp. trading on the Canadian Securities Exchange (“CSE”) under the symbol DOSE (“RDT” or the “Company“) announces the appointment of Mr. Peter Thilo Hasler to the board of directors. Mark Upsdell, CEO of RDT said...
August 11, 2020
Burlington, Ontario – August 11, 2020 – Rapid Dose Therapeutics Corp. trading on the Canadian Securities Exchange (“CSE”) under the symbol DOSE (“RDT” or the “Company“) announces that the Company, in conjunction with Leede Jones Gable, has received an initial advance from a strategic industry...
June 26, 2020
Burlington, Ontario – June 26, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”) announces that due to circumstances created by the COVID-19 pandemic, the Ontario Securities Commission and other members of the Canadian Securities Administrators granted “Issuers” in the Canadian securities...